SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 232 filers reported holding SAGE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,180 | +618.0% | 689 | +1540.5% | 0.00% | – |
| Q2 2023 | $1,975 | -24.1% | 42 | -32.3% | 0.00% | – |
| Q1 2023 | $2,602 | +62.4% | 62 | +47.6% | 0.00% | – |
| Q4 2022 | $1,602 | -46.6% | 42 | -37.3% | 0.00% | – |
| Q3 2022 | $3,000 | +50.0% | 67 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | +100.0% | 67 | +168.0% | 0.00% | – |
| Q1 2022 | $1,000 | -66.7% | 25 | -57.6% | 0.00% | – |
| Q4 2021 | $3,000 | +200.0% | 59 | +110.7% | 0.00% | – |
| Q3 2021 | $1,000 | -66.7% | 28 | -53.3% | 0.00% | – |
| Q2 2021 | $3,000 | -40.0% | 60 | -13.0% | 0.00% | -100.0% |
| Q1 2021 | $5,000 | -28.6% | 69 | -14.8% | 0.00% | 0.0% |
| Q4 2020 | $7,000 | +75.0% | 81 | +22.7% | 0.00% | 0.0% |
| Q3 2020 | $4,000 | +300.0% | 66 | +164.0% | 0.00% | – |
| Q2 2020 | $1,000 | -66.7% | 25 | -77.3% | 0.00% | -100.0% |
| Q1 2020 | $3,000 | – | 110 | +1471.4% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 7 | -96.0% | 0.00% | -100.0% |
| Q3 2019 | $23,000 | -62.9% | 176 | -49.4% | 0.00% | -60.0% |
| Q2 2019 | $62,000 | +17.0% | 348 | 0.0% | 0.01% | +11.1% |
| Q1 2019 | $53,000 | – | 348 | +4871.4% | 0.01% | – |
| Q4 2018 | $0 | – | 7 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 179,200 | $29,516,000 | 16.65% |
| TRV GP II, LLC | 547,916 | $90,247,000 | 16.25% |
| Opus Point Partners Management, LLC | 71,000 | $11,694,000 | 10.12% |
| Casdin Capital, LLC | 250,000 | $41,178,000 | 10.03% |
| RA Capital Management | 455,173 | $74,972,000 | 6.27% |
| Crawford Lake Capital Management, LLC | 154,278 | $25,411,000 | 6.00% |
| Palo Alto Investors LP | 810,806 | $133,548,000 | 5.75% |
| GREAT POINT PARTNERS LLC | 200,000 | $32,942,000 | 5.62% |
| BB BIOTECH AG | 1,042,439 | $171,700,000 | 4.84% |
| Crawford Lake Capital Management, LLC | 92,300 | $15,203,000 | 3.59% |